InvestorsHub Logo
Followers 17
Posts 899
Boards Moderated 0
Alias Born 09/28/2014

Re: Doc logic post# 402019

Tuesday, 09/14/2021 2:44:12 PM

Tuesday, September 14, 2021 2:44:12 PM

Post# of 704077

“Anyone in the industry see contracts for components like albumin or maturation products being set up for Charles Rivers Labs or Advent?”



Disclosure: I’m out of my league in answering this as I’m not in the industry, nor medical, legal or financial fields but I’ll give this a go:

Akron Biotech - AkronBiotech.com

Akron Bio had a partnership with Cognate a few years ago (2015) and they may be dealing with Charles River Lab. (ancillary materials)

Akron Bio announced recently that a recent agreement was signed with Octapharma a key market player (Albumin)

Akron’s VP of Business Development - Robert Margolin past executive at Cognate as well as TrakCel.

Arkron’s Scientific Board member - Anthony Davies CEO of Dark Horse Consulting (also advisor to CRL /Cognate acquisition)

Note: I hope my scribbled notes offered some info.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News